Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With DiabetesAnn. Intern. Med 2023 May 09;[EPub Ahead of Print], TL Richardson, AE Halvorson, AJ Hackstadt, AM Hung, R Greevy, CG Grijalva, TA Elasy, CL Roumie
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.